GC
KDNY

Guggenheim Capital’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Guggenheim Capital’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7,750
Closed -$298K – 1946
2023
Q2 		$298K Buy
+7,750
New +$298K ﹤0.01% 1662